M. Kaye Kramer

2.2k total citations
51 papers, 1.4k citations indexed

About

M. Kaye Kramer is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacy and Public Health, Environmental and Occupational Health. According to data from OpenAlex, M. Kaye Kramer has authored 51 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Pharmacy and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in M. Kaye Kramer's work include Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers), Obesity and Health Practices (15 papers) and Diabetes Management and Education (13 papers). M. Kaye Kramer is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers), Obesity and Health Practices (15 papers) and Diabetes Management and Education (13 papers). M. Kaye Kramer collaborates with scholars based in United States, Norway and Argentina. M. Kaye Kramer's co-authors include Elizabeth M. Venditti, Andrea M. Kriska, Linda M. Siminerio, Rachel G. Miller, Trevor J. Orchard, Maria M. Brooks, Lora E. Burke, Francis X. Solano, Vincent C. Arena and Hsiang‐Yu Chen and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Medicine & Science in Sports & Exercise.

In The Last Decade

M. Kaye Kramer

50 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Kaye Kramer United States 19 601 432 324 312 250 51 1.4k
John M. Boltri United States 19 365 0.6× 420 1.0× 367 1.1× 178 0.6× 160 0.6× 51 1.2k
Marni J. Armstrong Canada 11 545 0.9× 314 0.7× 278 0.9× 160 0.5× 336 1.3× 23 1.3k
Sue Cradock United Kingdom 19 1.1k 1.8× 487 1.1× 180 0.6× 139 0.4× 123 0.5× 53 1.7k
W. S. Leslie United Kingdom 20 306 0.5× 171 0.4× 291 0.9× 181 0.6× 631 2.5× 41 1.3k
Heikki Heinonen Finland 13 297 0.5× 260 0.6× 211 0.7× 138 0.4× 137 0.5× 17 995
Sami Heistaro Finland 14 223 0.4× 383 0.9× 220 0.7× 98 0.3× 155 0.6× 23 1.2k
Evelyn Wong Singapore 19 201 0.3× 200 0.5× 448 1.4× 88 0.3× 352 1.4× 58 1.4k
Megan Dalton Australia 14 247 0.4× 309 0.7× 843 2.6× 139 0.4× 526 2.1× 31 1.7k
Marian Carey United Kingdom 17 1.4k 2.4× 485 1.1× 266 0.8× 146 0.5× 129 0.5× 40 2.0k
Robert G. Holleman United States 20 126 0.2× 375 0.9× 362 1.1× 107 0.3× 582 2.3× 39 1.3k

Countries citing papers authored by M. Kaye Kramer

Since Specialization
Citations

This map shows the geographic impact of M. Kaye Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Kaye Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Kaye Kramer more than expected).

Fields of papers citing papers by M. Kaye Kramer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Kaye Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Kaye Kramer. The network helps show where M. Kaye Kramer may publish in the future.

Co-authorship network of co-authors of M. Kaye Kramer

This figure shows the co-authorship network connecting the top 25 collaborators of M. Kaye Kramer. A scholar is included among the top collaborators of M. Kaye Kramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Kaye Kramer. M. Kaye Kramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Driver, Simon, Chad Swank, Monica Bennett, et al.. (2022). Efficacy of the Diabetes Prevention Program Group Lifestyle Balance Program Modified for Individuals with TBI (GLB-TBI): Results from a 12-month Randomized Controlled Trial. Annals of Behavioral Medicine. 57(2). 131–145. 7 indexed citations
3.
Froehlich-Grobe, Katherine, et al.. (2020). Group Lifestyle Balance Adapted for Individuals With Impaired Mobility: Outcomes for 6-Month RCT and Combined Groups at 12 Months. American Journal of Preventive Medicine. 59(6). 805–817. 10 indexed citations
4.
Driver, Simon, et al.. (2018). Impact of a Community-Based Healthy Lifestyle Program on Individuals With Traumatic Brain Injury. Journal of Head Trauma Rehabilitation. 33(6). E49–E58. 17 indexed citations
5.
Eaglehouse, Yvonne L., Elizabeth M. Venditti, M. Kaye Kramer, et al.. (2017). Factors related to lifestyle goal achievement in a diabetes prevention program dissemination study. Translational Behavioral Medicine. 7(4). 873–880. 15 indexed citations
6.
Eaglehouse, Yvonne L., et al.. (2016). Impact of a community-based lifestyle intervention program on health-related quality of life. Quality of Life Research. 25(8). 1903–1912. 35 indexed citations
7.
Rosas, Lisa G., Nan Lv, Lan Xiao, et al.. (2016). Evaluation of a culturally-adapted lifestyle intervention to treat elevated cardiometabolic risk of Latino adults in primary care (Vida Sana): A randomized controlled trial. Contemporary Clinical Trials. 48. 30–40. 22 indexed citations
8.
Kramer, M. Kaye, et al.. (2015). Recruitment for a Diabetes Prevention Program translation effort in a worksite setting. Contemporary Clinical Trials. 41. 204–210. 14 indexed citations
9.
Kramer, M. Kaye, Vincent C. Arena, Elizabeth M. Venditti, et al.. (2015). Improving Employee Health. Journal of Occupational and Environmental Medicine. 57(3). 284–291. 61 indexed citations
10.
Sattin, Richard W., Lovoria B. Williams, James W. Dias, et al.. (2015). Community Trial of a Faith-Based Lifestyle Intervention to Prevent Diabetes Among African-Americans. Journal of Community Health. 41(1). 87–96. 82 indexed citations
11.
Eaglehouse, Yvonne L., M. Kaye Kramer, Bonny Rockette‐Wagner, Vincent C. Arena, & Andrea M. Kriska. (2015). Evaluation of physical activity reporting in community Diabetes Prevention Program lifestyle intervention efforts: A systematic review. Preventive Medicine. 77. 191–199. 13 indexed citations
12.
Kramer, M. Kaye, et al.. (2013). Evaluation of the Group Lifestyle Balance programme for diabetes prevention in a Hispanic Women, Infants and Children (WIC) Programme population in the USA. Diversity & Equality in Health and Care. 10(2). 8 indexed citations
13.
Venditti, Elizabeth M. & M. Kaye Kramer. (2012). Necessary Components for Lifestyle Modification Interventions to Reduce Diabetes Risk. Current Diabetes Reports. 12(2). 138–146. 49 indexed citations
14.
Kramer, M. Kaye, Andrea M. Kriska, Elizabeth M. Venditti, et al.. (2009). Translating the Diabetes Prevention Program. American Journal of Preventive Medicine. 37(6). 505–511. 280 indexed citations
15.
Walker, Elizabeth A., Mark E. Molitch, M. Kaye Kramer, et al.. (2006). Adherence to Preventive Medications. Diabetes Care. 29(9). 1997–2002. 126 indexed citations
16.
Dorman, Janice S., Bridget J. McCarthy, Erin C. McCanlies, et al.. (1996). Molecular IDDM epidemiology: international studies. Diabetes Research and Clinical Practice. 34. S107–S116. 16 indexed citations
17.
Kramer, M. Kaye, et al.. (1995). Dietary Intake of Patients With Insulin-Dependent Diabetes Mellitus Compared With Nutrition Guidelines. Journal of the American Dietetic Association. 95(11). 1317–1319. 1 indexed citations
18.
Pierce, John P., N Evans, A. J. Farkas, et al.. (1994). Tobacco Use in California: An Evaluation of the Tobacco Control Program, 1989-1993. A Report to the California Department of Health Services. Tobacco Control. 9 indexed citations
19.
Pierce, John P., N Evans, Charles C. Berry, et al.. (1994). Tobacco Use in California An Evaluation of the Tobacco Contol Program, 1989-1993. Tobacco Control. 14 indexed citations
20.
Kramer, M. Kaye, et al.. (1975). A double-blind evaluation of metiapine in hospitalized acute schizophrenics.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 18(6). 839–48. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John M. Boltri Breakdown of academic impact, for papers by Marni J. Armstrong Breakdown of academic impact, for papers by Sue Cradock Breakdown of academic impact, for papers by W. S. Leslie Breakdown of academic impact, for papers by Heikki Heinonen Breakdown of academic impact, for papers by Sami Heistaro Breakdown of academic impact, for papers by Evelyn Wong Breakdown of academic impact, for papers by Megan Dalton Breakdown of academic impact, for papers by Marian Carey Breakdown of academic impact, for papers by Robert G. Holleman
Rankless by CCL
2026